CV CapsoVision, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$6.17
· of 52w range
· above low
· to high
$4.3852w low
$15.0052w high
Market Cap (MRQ)
$309M
P/E (TTM)
-13.7
EPS (TTM)
$-0.45
Revenue (TTM)
$14M
your badges
52W Range
$4–$15
Analyst Rating
BUY
Price Target
$10
P/E
-13.7
ROE
47.4%
Net Profit Margin
-214.7%
Your badge strip is empty — pin a metric anywhere on this page.
CV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.17
Market Cap (MRQ)
$309M
P/E (TTM)
-13.7
EPS (TTM)
$-0.45
Revenue (TTM)
$14M
ROE (TTM)
47.4%
52W Range
$4–$15
CV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$14M2024-12-31 → 2025-12-31
EPS$-1.032024-12-31 → 2025-12-31
Free Cash Flow$-23M2025-12-31 → 2025-12-31
Net margin-214.7%2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -13.7 | · | · | · | |
| P/S (TTM) | 22.2 | · | 4.5 | Overvalued | |
| P/B (MRQ) | 23.4 | · | 3.5 | Overvalued | |
| Price / FCF (TTM) | -11.1 | · | · | · | |
| Price / Cash Flow (TTM) | -11.1 | · | · | · | |
| Price / Tangible Book | 23.2 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 50.9% | · | 73.9% | Weak | |
| Operating Margin (TTM) | -217.1% | · | -76.2% | Weak | |
| EBITDA Margin (TTM) | -215.5% | · | -76.2% | Weak | |
| Pretax Margin (TTM) | -214.6% | · | -104.6% | Weak | |
| Net Profit Margin (TTM) | -214.7% | · | -79.8% | Weak | |
| ROA (TTM) | -212.2% | · | -32.6% | Weak | |
| ROE (TTM) | 47.4% | · | -63.8% | Top tier | |
| ROIC | -192.6% | · | -50.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 3.4 | · | 4.0 | Below avg | |
| Quick Ratio | 0.6 | · | 2.7 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 15.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.8 | · | 0.6 | Top tier | |
| Inventory Turnover | 2.3 | · | 1.9 | Top tier | |
| Receivables Turnover | 6.0 | · | 6.0 | In line | |
| Revenue / Employee | ≈$136.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-330.5%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.15 | $-0.13 | -12.0% |
| March 31, 2026 | May 14, 2026 | $-0.15 | $-0.13 | -12.0% |
| Dec. 31, 2025 | $-0.02 | $-0.15 | 86.6% | |
| Sept. 30, 2025 | $-0.17 | $-0.13 | -32.0% | |
| June 30, 2025 | $-2.02 | $-0.11 | -1682.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $14M | $12M | |
| Cost of Revenue | $6M | $5M | |
| Gross Profit | $7M | $6M | |
| R&D Expense | $18M | $15M | |
| SG&A Expense | $7M | $4M | |
| Operating Expenses | $33M | $26M | |
| Operating Income | $-26M | $-20M | |
| Other Non-op | $-44.0K | $4.0K | |
| Pretax Income | $-25M | $-20M | |
| Income Tax | $24.0K | $11.0K | |
| Net Income | $-25M | $-20M | |
| EPS (Basic) | $-1.03 | $-9.85 | |
| EPS (Diluted) | $-1.03 | $-9.85 | |
| Shares (Basic) | 24,555,381 | 2,020,077 | |
| Shares (Diluted) | 24,555,381 | 2,020,077 | |
| EBITDA | $-25M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Receivables | $2M | $2M | |
| Inventory | $3M | $3M | |
| Prepaid Expense | $1M | $898.0K | |
| Other Current Assets | $448.0K | $260.0K | |
| Current Assets | $17M | $15M | |
| PP&E (Net) | $611.0K | $720.0K | |
| Accum. Depreciation | $575.0K | $359.0K | |
| Other Non-current Assets | $41.0K | $41.0K | |
| Total Assets | $18M | $17M | |
| Accounts Payable | $1M | $749.0K | |
| Accrued Liabilities | $3M | $569.0K | |
| Current Liabilities | $4M | $2M | |
| Capital Leases | $477.0K | $887.0K | |
| Total Liabilities | $5M | $3M | |
| Common Stock | $47.0K | $2.0K | |
| Paid-in Capital | $169M | $838.0K | |
| Retained Earnings | $-156M | $-130M | |
| Stockholders' Equity | $13M | $-130M | |
| Liabilities + Equity | $18M | $17M | |
| Shares Outstanding | 46,865,051 | 2,090,945 |
Cash Flow
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $216.0K | $206.0K | |
| Stock-based Comp | $826.0K | $156.0K | |
| Deferred Tax | $0 | $0 | |
| Other Non-cash | $1M | · | |
| Operating Cash Flow | $-23M | $-20M | |
| CapEx | $90.0K | $153.0K | |
| Investing Cash Flow | $-90.0K | $-153.0K | |
| Financing Cash Flow | $24M | $15M | |
| Free Cash Flow | $-23M | · |
Profitability
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | 52.9% | · | |
| Operating Margin | -188.2% | · | |
| Net Margin | -186.8% | · | |
| Pretax Margin | -186.6% | · | |
| EBITDA Margin | -186.7% | · | |
| ROA | -144.8% | · | |
| ROE | 40.3% | · | |
| ROIC | -192.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 3.8 | · | |
| Quick Ratio | 0.6 | · |
Efficiency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.8 | · | |
| Inventory Turnover | 2.3 | · | |
| Receivables Turnover | 6.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | $0.28 | · | |
| Revenue / Share | $0.55 | · | |
| Cash Flow / Share | $-0.93 | · | |
| EPS (TTM) | $-1.03 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 15.3% | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $14M | · | |
| Net Income TTM | $-25M | · | |
| Market Cap | $501M | · | |
| P/E | -10.4 | · | |
| P/S | 37.0 | · | |
| P/B | 37.8 | · | |
| P / Tangible Book | 37.8 | · | |
| P / Cash Flow | -21.9 | · | |
| P / FCF | -21.8 | · | |
| Earnings Yield | -9.6% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | |
| Gross Profit | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | |
| R&D Expense | $5M | $4M | $6M | $6M | $3M | $3M | $3M | $5M | $4M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $857.0K | |
| Operating Expenses | $9M | $8M | $9M | $10M | $6M | $7M | $6M | $7M | $7M | |
| Operating Income | $-8M | $-7M | $-7M | $-8M | $-5M | $-5M | $-5M | $-6M | $-5M | |
| Other Non-op | $17.0K | $1.0K | $0 | $-34.0K | $-11.0K | $1.0K | $2.0K | $1.0K | $0 | |
| Pretax Income | $-7M | $-7M | $-7M | $-8M | $-5M | $-5M | $-5M | $-6M | $-5M | |
| Income Tax | $0 | $0 | $24.0K | $0 | $0 | $0 | $11.0K | $0 | $0 | |
| Net Income | $-7M | $-7M | $-7M | $-8M | $-5M | $-5M | $-5M | $-6M | $-5M | |
| EPS (Basic) | $-0.15 | $-0.15 | $0.02 | $-0.17 | $-2.02 | $-2.49 | $-2.20 | $-2.79 | $-2.58 | |
| EPS (Diluted) | $-0.15 | $-0.15 | $0.02 | $-0.17 | $-2.02 | $-2.49 | $-2.20 | $-2.79 | $-2.58 | |
| Shares (Basic) | 49,937,525 | 47,456,908 | · | 46,217,127 | 2,292,230 | 2,157,627 | · | 2,076,979 | 2,042,111 | |
| Shares (Diluted) | 49,937,525 | 47,456,908 | · | 46,217,127 | 2,292,230 | 2,157,627 | · | 2,076,979 | 2,042,111 | |
| EBITDA | $-8M | $-7M | · | $-8M | $-5M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $2M | $2M | $2M | $2M | $2M | · | $2M | · | · | |
| Inventory | $5M | $3M | $3M | $3M | $3M | · | $3M | · | · | |
| Prepaid Expense | $1M | $1M | $1M | $1M | $2M | · | $898.0K | · | · | |
| Other Current Assets | $567.0K | $527.0K | $448.0K | $373.0K | $433.0K | · | $260.0K | · | · | |
| Current Assets | $17M | $24M | $17M | $24M | $8M | · | $15M | · | · | |
| PP&E (Net) | $562.0K | $620.0K | $611.0K | $640.0K | $683.0K | · | $720.0K | · | · | |
| Accum. Depreciation | $689.0K | $631.0K | $575.0K | $520.0K | $466.0K | · | $359.0K | · | · | |
| Other Non-current Assets | $76.0K | $76.0K | $41.0K | $41.0K | $41.0K | · | $41.0K | · | · | |
| Total Assets | $19M | $26M | $18M | $26M | $10M | · | $17M | · | · | |
| Accounts Payable | $475.0K | $1M | $1M | $1M | $1M | · | $749.0K | · | · | |
| Accrued Liabilities | $4M | $3M | $3M | $3M | $2M | · | $569.0K | · | · | |
| Current Liabilities | $5M | $5M | $4M | $5M | $4M | · | $2M | · | · | |
| Capital Leases | $245.0K | $362.0K | $477.0K | $584.0K | $687.0K | · | $887.0K | · | · | |
| Total Liabilities | $5M | $6M | $5M | $5M | $5M | · | $3M | · | · | |
| Common Stock | $50.0K | $50.0K | $47.0K | $47.0K | $2.0K | · | $2.0K | · | · | |
| Paid-in Capital | $183M | $183M | $169M | $169M | $1M | · | $838.0K | · | · | |
| Retained Earnings | $-170M | $-163M | $-156M | $-148M | $-140M | · | $-130M | · | · | |
| Stockholders' Equity | $13M | $20M | $13M | $20M | $-139M | · | $-130M | · | · | |
| Liabilities + Equity | $19M | $26M | $18M | $26M | $10M | · | $17M | · | · | |
| Shares Outstanding | 50,032,148 | 49,838,867 | 46,865,051 | 46,798,901 | 2,459,183 | · | 2,090,945 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $58.0K | $56.0K | $55.0K | $54.0K | $55.0K | $52.0K | $51.0K | $52.0K | $52.0K | |
| Stock-based Comp | $577.0K | $334.0K | $197.0K | $307.0K | $170.0K | $152.0K | $113.0K | $15.0K | · | |
| Other Non-cash | · | $577.0K | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-8M | $-6M | $-8M | $-6M | $-5M | $-5M | $-5M | $-7M | · | |
| CapEx | $0 | $48.0K | $8.0K | $12.0K | $30.0K | $40.0K | $0 | $4.0K | · | |
| Investing Cash Flow | $0 | $-48.0K | $-8.0K | $-12.0K | $-30.0K | $-40.0K | $0 | $-4.0K | · | |
| Financing Cash Flow | $-443.0K | $14M | $15.0K | $22M | $1M | $34.0K | $5M | $10M | · | |
| Free Cash Flow | · | $-6M | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.4% | 47.6% | · | 54.1% | 54.6% | · | · | · | · | |
| Operating Margin | -208.1% | -254.1% | · | -226.7% | -140.3% | · | · | · | · | |
| Net Margin | -205.4% | -251.9% | · | -223.9% | -139.5% | · | · | · | · | |
| Pretax Margin | -205.4% | -251.9% | · | -223.9% | -139.5% | · | · | · | · | |
| EBITDA Margin | -206.5% | -252.0% | · | -225.1% | -138.6% | · | · | · | · | |
| ROA | -53.2% | -54.2% | · | -61.7% | -96.9% | · | · | · | · | |
| ROE | 11.9% | -69.6% | · | -77.5% | 6.7% | · | · | · | · | |
| ROIC | -57.6% | -35.1% | · | -39.2% | 3.4% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.6 | · | 5.2 | 1.8 | · | · | · | · | |
| Quick Ratio | 0.4 | 0.4 | · | 0.4 | 0.4 | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.3 | 0.7 | · | · | · | · | |
| Inventory Turnover | 0.5 | 0.8 | · | 1.0 | 1.0 | · | · | · | · | |
| Receivables Turnover | 1.8 | 2.9 | · | 3.8 | 3.6 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.26 | $0.41 | · | $0.44 | $-56.52 | · | · | · | · | |
| Revenue / Share | $0.07 | $0.06 | · | $0.08 | $1.45 | · | · | · | · | |
| Cash Flow / Share | · | $-0.13 | · | · | · | · | · | · | · | |
| EPS (TTM) | $-0.45 | $-2.32 | · | $-6.88 | $-9.50 | $-10.06 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14M | $14M | · | $13M | $13M | $12M | · | · | · | |
| Net Income TTM | $-30M | $-27M | · | $-23M | $-20M | $-21M | · | · | · | |
| Market Cap | $379M | $363M | · | $227M | · | · | · | · | · | |
| P/E | -16.8 | -3.1 | · | -0.7 | · | · | · | · | · | |
| P/S | 27.3 | 26.8 | · | 17.3 | · | · | · | · | · | |
| P/B | 28.8 | 18.0 | · | 11.1 | · | · | · | · | · | |
| P / Tangible Book | 28.8 | 18.0 | · | 11.1 | · | · | · | · | · | |
| P / Cash Flow | · | -59.9 | · | · | · | · | · | · | · | |
| Earnings Yield | -5.9% | -31.8% | · | -142.2% | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $14M | $12M |
| Gross Margin % | 52.9% | · |
| Operating Margin % | -188.2% | · |
| Net Income | $-25M | $-20M |
| Diluted EPS | $-1.03 | $-9.85 |
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Current Ratio | 3.8 | · |
| Quick Ratio | 0.6 | · |
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Free Cash Flow | $-23M | · |
Institutional owners (13F) 51 filers · $39.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
51
Value held
$39.8M
New positions
5
Exited positions
6
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-18 vs prior Q) | 6 (+3 vs prior Q) | 31 (+7 vs prior Q) | 7 (+6 vs prior Q) | +1.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $14,372,347 | 1,896,088 | 36.08% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $8,023,187 | 1,058,468 | 20.14% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $4,385,200 | 578,482 | 11.01% | Shares |
| STATE STREET CORP | $3,109,627 | 410,241 | 7.81% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,822,422 | 240,425 | 4.57% | Shares |
| NORTHERN TRUST CORP | $1,668,320 | 220,095 | 4.19% | Shares |
| VANGUARD GROUP INC | $1,434,364 | 134,178 | 3.60% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $785,515 | 103,630 | 1.97% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $601,549 | 79,360 | 1.51% | Shares |
| Bank of New York Mellon Corp | $568,657 | 75,021 | 1.43% | Shares |
| Nuveen, LLC | $348,763 | 46,011 | 0.88% | Shares |
| DEUTSCHE BANK AG\ | $263,026 | 34,700 | 0.66% | Shares |
| XTX Topco Ltd | $241,385 | 31,845 | 0.61% | Shares |
| WELLS FARGO & COMPANY/MN | $241,196 | 31,820 | 0.61% | Shares |
| BANK OF AMERICA CORP /DE/ | $193,055 | 25,469 | 0.48% | Shares |
| RHUMBLINE ADVISERS | $166,520 | 21,969 | 0.42% | Shares |
| MetLife Investment Management, LLC | $160,044 | 21,114 | 0.40% | Shares |
| Invesco Ltd. | $142,709 | 18,827 | 0.36% | Shares |
| MORGAN STANLEY | $141,921 | 18,723 | 0.36% | Shares |
| GOLDMAN SACHS GROUP INC | $141,193 | 18,627 | 0.35% | Shares |
| CITIGROUP INC | $124,191 | 16,384 | 0.31% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $121,765 | 16,064 | 0.31% | Shares |
| JPMORGAN CHASE & CO | $109,828 | 14,566 | 0.28% | Shares |
| Russell Investments Group, Ltd. | $109,523 | 14,449 | 0.27% | Shares |
| Police & Firemen's Retirement System of New Jersey | $100,640 | 13,277 | 0.25% | Shares |
| BARCLAYS PLC | $89,414 | 11,796 | 0.22% | Shares |
| Connective Capital Management, LLC | $75,504 | 9,961 | 0.19% | Shares |
| UBS Group AG | $55,311 | 7,297 | 0.14% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $53,924 | 7,114 | 0.14% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $42,251 | 5,574 | 0.11% | Shares |
| FMR LLC | $31,836 | 4,200 | 0.08% | Shares |
| Legal & General Group Plc | $25,749 | 3,397 | 0.06% | Shares |
| Vanguard Global Advisers, LLC | $19,253 | 2,540 | 0.05% | Shares |
| Tower Research Capital LLC (TRC) | $18,814 | 2,482 | 0.05% | Shares |
| Ameritas Investment Partners, Inc. | $17,275 | 2,279 | 0.04% | Shares |
| ROYAL BANK OF CANADA | $12,000 | 1,566 | 0.03% | Shares |
| TD Waterhouse Canada Inc. | $11,041 | 1,500 | 0.03% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2,964 | 391 | 0.01% | Shares |
| GAMMA Investing LLC | $1,023 | 135 | 0.00% | Shares |
| Sterling Capital Management LLC | $925 | 122 | 0.00% | Shares |
| Physician Wealth Advisors, Inc. | $630 | 83 | 0.00% | Shares |
| Arax Advisory Partners | $598 | 79 | 0.00% | Shares |
| CWM, LLC | $386 | 53 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $221 | 29,026 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $182 | 24 | 0.00% | Shares |
| Allworth Financial LP | $114 | 15 | 0.00% | Shares |
| True Wealth Design, LLC | $107 | 14 | 0.00% | Shares |
| Farther Finance Advisors, LLC | $99 | 13 | 0.00% | Shares |
| Transamerica Financial Advisors, LLC | $83 | 11 | 0.00% | Shares |
| EverSource Wealth Advisors, LLC | $38 | 5 | 0.00% | Shares |
Company insiders 13 insiders · 3 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Kang-Huai Wang | President and Chief Executive Officer | June 1, 2026 A | 721,732 | 0 | 0 | $0 |
| David Michael Garcia | Sr. VP of Finance | June 1, 2026 A | · | 0 | 0 | $0 |
| Douglas Patrick Atkinson | Head of Global Sales | June 1, 2026 A | 107,357 | 0 | 0 | $0 |
| David Stanley Shields | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Hui Ying Kuo | Director | June 30, 2026 M | 15,263 | 0 | 0 | $0 |
| Wen-Herng Henry King | Director | June 30, 2026 M | 25,619 | 0 | 0 | $0 |
| Michele Harari | Director | June 30, 2026 M | 61,065 | 0 | 0 | $0 |
| Chen Lung Tsai | Director | June 30, 2026 M | 4,929 | 1 | 0 | $83 |
| Julia S Gouw | Director | June 30, 2026 M | 4,909 | 0 | 0 | $0 |
| Joanne Carol Imperial | Director | June 8, 2026 S | 1,687 | 0 | 1 | $-8,592 |
| Eliyahou Harari ET AL | 10% owner | Sept. 18, 2026 P | 878,734 | 5 | 0 | $11,007,901 |
| Ching Hang Shen | 10% owner | April 17, 2026 J | 6,400,527 | 2 | 0 | $9,999,992 |
| Rebecca Ann Petersen | · | Aug. 18, 2025 M | 24,834 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 9 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.05% | 118,479 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 37,129 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 327,580 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 200,803 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 16,675 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 829,254 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 100,983 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 925,200 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,493 SH | Aug. 19, 2026 | Daily |
CV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$9.50
+54.0%
3 30.0%
Strong Buy
6 60.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-10-03Mean target $9.50 +54.0%
← Below all targets
Current price $6.17
Low$9.00
Mean$9.50
High$10.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | · |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| MOBI | · | · | · | · | · | · |
| TMCI | · | -2.6 | 1.6% | -27.7% | -63.8% | 79.8% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Latest News Recent headlines mentioning this company
How recent grads and college students should be thinking about AI, the CV, and the job market
CNBC · 1 week ago
Here’s Why Amgen (AMGN) is Among the 7 Best Longevity Stocks to Buy Now
Yahoo Finance · 3 months, 2 weeks ago
'I ended up paying £500': Your subscription trap stories
BBC Business · 5 months, 4 weeks ago
Oversold Conditions For Coca-Cola FEMSA SAB (KOF)
Nasdaq · 6 months, 1 week ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026